Comparative analysis of maternal-fetal interface in preeclampsia and preterm labor

Cell and Tissue Research

Volumn 329, Issue 3, 2007, Pages 559-569

  Zhou, Yan ^a   Bianco, Katherine ^b   Huang, Ling ^a   Nien, Jyh K ^c   McMaster, Michael ^a   Romero, Roberto ^c   Fisher, Susan J ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Human; Placenta; Preeclampsia; Pregnancy; Preterm birth; Trophoblast

Indexed keywords

ANTIGEN;

ADULT; ARTICLE; CELL STRUCTURE; CONTROLLED STUDY; CYTOTROPHOBLAST; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MOTHER FETUS RELATIONSHIP; PHENOTYPE; PREECLAMPSIA; PREMATURE LABOR; PRIORITY JOURNAL;

ADULT; CASE-CONTROL STUDIES; FEMALE; GESTATIONAL AGE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; INFLAMMATION; INTEGRIN ALPHA CHAINS; OBSTETRIC LABOR, PREMATURE; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; TROPHOBLASTS;

EID: 34547820861     PISSN: 0302766X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00441-007-0428-0     Document Type: Article

References (40)

1. ACOG (2000) ACOG practice bulletin. Intrauterine growth restriction: clinical management guidelines for obstetrician-gynecologists. Am College Obstet Gynecol 12:1-11
2. Alexander GR, Himes JH, Kaufman RB, Mor J, Kogan M (1996) A United States national reference for fetal growth. Obstet Gynecol 87:163-168
3. Benirschke K, Kaufmann P (2000) Pathology of the human placenta. Springer, Berlin Heidelberg New York
4. Brosens IA, Robertson WB, Dixon HG (1972) The role of the spiral arteries in the pathogenesis of preeclampsia. Obstet Gynecol Annu 1:177-191
5. Chesley LC (1985) Diagnosis of preeclampsia. Obstet Gynecol 65:423-425
6. Fisher S, Genbacev O, Maidji E, Pereira L (2000) Human cytomegalovirus infection of placental cytotrophoblasts in vitro and in utero: implications for transmission and pathogenesis. J Virol 74:6808-6820
7. Genbacev O, Zhou Y, Ludlow JW, Fisher SJ (1997) Regulation of human placental development by oxygen tension. Science 277:1669-1672
8. Gerretsen G, Huisjes HJ, Elema JD (1981) Morphological changes of the spiral arteries in the placental bed in relation to pre-eclampsia and fetal growth retardation. Br J Obstet Gynaecol 88:876-881
9. Goldenberg RL, Rouse DJ (1998) Prevention of premature birth. N Engl J Med 339:313-320
10. Goldman-Wohl DS, Ariel I, Greenfield C, Hochner-Celnikier D, Cross J, Fisher S, Yagel S (2000) Lack of human leukocyte antigen-G expression in extravillous trophoblasts is associated with pre-eclampsia. Mol Hum Reprod 6:88-95
11. Gomez O, Martinez JM, Figueras F, Del Rio M, Borobio V, Puerto B, Coll O, Cararach V, Vanrell JA (2005) Uterine artery Doppler at 11-14 weeks of gestation to screen for hypertensive disorders and associated complications in an unselected population. Ultrasound Obstet Gynecol 26:490-494
12. Herron MA, Katz M, Creasy RK (1982) Evaluation of a preterm birth prevention program: preliminary report. Obstet Gynecol 59:452-456
13. Hershkovitz R, Swiet M de, Kingdom J (2005) Mid-trimester placentation assessment in high-risk pregnancies using maternal serum screening and uterine artery Doppler. Hypertens Pregnancy 24:273-280
14. Hiby SE, Walker JJ, O'Shaughnessy KM, Redman CW, Carrington M, Trowsdale J, Moffett A (2004) Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med 200:957-965
15. Janatpour MJ, Utset MF, Cross JC, Rossant J, Dong J, Israel MA, Fisher SJ (1999) A repertoire of differentially expressed transcription factors that offers insight into mechanisms of human cytotrophoblast differentiation. Dev Genet 25:146-157
16. Kaufmann P, Huppertz B, Frank HG (1996) The fibrinoids of the human placenta: origin, composition and functional relevance. Ann Anat 178:485-501
17. Khong TY, De Wolf F, Robertson WB, Brosens I (1986) Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol 93:1049-1059
18. Lain KY, Roberts JM (2002) Contemporary concepts of the pathogenesis and management of preeclampsia. JAMA 287:3183-3186
19. Lam C, Lim KH, Karumanchi SA (2005) Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia. Hypertension 46:1077-1085
20. McMaster MT, Librach CL, Zhou Y, Lim KH, Janatpour MJ, DeMars R, Kovats S, Damsky C, Fisher SJ (1995) Human placental HLA-G expression is restricted to differentiated cytotrophoblasts. J Immunol 154:3771-3778
21. McMaster MT, Zhou Y, Fisher SJ (2004) Abnormal placentation and the syndrome of preeclampsia. Semin Nephrol 24:540-547
22. Moodley J, Ramsaroop R (1989) Placental bed morphology in black women with eclampsia. S Afr Med J 75:376-378
23. Naicker T, Khedun SM, Moodley J, Pijnenborg R (2003) Quantitative analysis of trophoblast invasion in preeclampsia. Acta Obstet Gynecol Scand 82:722-729
24. Ness RB, Roberts JM (1996) Heterogeneous causes constituting the single syndrome of preeclampsia: a hypothesis and its implications. Am J Obstet Gynecol 175:1365-1370
25. Red-Horse K, Zhou Y, Genbacev O, Prakobphol A, Foulk R, McMaster M, Fisher SJ (2004) Trophoblast differentiation during embryo implantation and formation of the maternal fetal interface. J Clin Invest 114:744-754
26. Redman CW, Sargent IL (2005) Latest advances in understanding preeclampsia. Science 308:1592-1594
27. Roberts JM (1998) Endothelial dysfunction in preeclampsia. Semin Reprod Endocrinol 16:5-15
28. Roberts JM, Cooper DW (2001) Pathogenesis and genetics of pre-eclampsia. Lancet 357:53-56
29. Roberts JM, Gammill HS (2005) Preeclampsia: recent insights. Hypertension 46:1243-1249
30. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK (1989) Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 161:1200-1204
31. Roberts JM, Pearson G, Cutler J, Lindheimer M (2003) Summary of the NHLBI working group on research on hypertension during pregnancy. Hypertension 41:437-445
32. Rodie VA, Freeman DJ, Sattar N, Greer IA (2004) Pre-eclampsia and cardiovascular disease: metabolic syndrome of pregnancy? Atherosclerosis 175:189-202
33. Sibai BM (1990) The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): much ado about nothing? Am J Obstet Gynecol 162:311-316
34. Sibai BM (1996) Treatment of hypertension in pregnant women. N Engl J Med 335:257-265
35. Sibai BM, Ewell M, Levine RJ, Klebanoff MA, Esterlitz J, Catalano PM, Goldenberg RL, Joffe G (1997) Risk factors associated with preeclampsia in healthy nulliparous women. The Calcium for Preeclampsia Prevention (CPEP) Study Group. Am J Obstet Gynecol 177:1003-1010
36. Stella CL, Sibai BM (2006) Preeclampsia: diagnosis and management of the atypical presentation. J Matern Fetal Neonatal Med 19:381-386
37. Tenney B, Parker F (1940) The placenta in toxemia of pregnancy. Am J Obstet Gynecol 39:1000-1005
38. Winn VD, Haimov-Kochman R, Paquet AC, Yang J, Madhusudhan MS, Gormley M, Feng KT, Bernlohr DA, McDonagh S, Pereira L, Sali A, Fisher SJ (2007) Gene expression profiling of the human maternal-fetal interface reveals dramatic changes between midgestation and term. Endocrinology 148:1059-1079
39. Zhou Y, Damsky CH, Chiu K, Roberts JM, Fisher SJ (1993) Preeclampsia is associated with abnormal expression of adhesion molecules by invasive cytotrophoblasts. J Clin Invest 91:950-960
40. Zhou Y, Damsky CH, Fisher SJ (1997) Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome? J Clin Invest 99:2152-2164